SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63365 356 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
63049atnm forgetme-3/29/2025
63048bcab epcam tce is progressing! Next dose escalation will be therapeutic forgetme-3/29/2025
63047actinium forgetme-3/29/2025
63046$BLUE. Receives competing bid finance.yahoo.comchandler2713/29/2025
63045Agreed on all of this and I have a sizable position as well. What's your taksukit-3/21/2025
63044Here is an article this morning from Reuters that explains some of the negative luckydog88-3/21/2025
63043SRPT is still over 10% of my portfolio. Less so than before due to the price drstockdoc77103/20/2025
63042Cantor Fitzgerald analyst Kristen Kluska reiterates Sarepta Therapeutics(SRPT) wluckydog8813/19/2025
63041Couple more analysts this morning: Deutsche Bank analyst David Hoang maintains luckydog88-3/19/2025
63040Needham analyst Gil Blum reiterates Sarepta Therapeutics(SRPT) with a Buy and maluckydog8823/18/2025
63039I want more information, but this appears to be a likely opportunity to pick up Olecranon13/18/2025
63038Picked some more up since this seems to be a one offerippetoe-3/18/2025
63037SRPT: investorrelations.sarepta.com Unfortunately true, a patient died due to aerickerickson13/18/2025
63036Sarepta down 18% in pre-market. Rumor is patient death from a dear doctor letteraudioWCAG2.113/18/2025
63035Biolata EpCAM is overexpressed in a wide range of tumors, making it an ideaforgetme-3/16/2025
63034Biolata EpCAM is overexpressed in a wide range of tumors, making it an ideaforgetme-3/16/2025
63033biolata Tce program will have data at asco. Co has disclosed mtd has not been reforgetme-3/16/2025
63032No one here paying attention? investors.meiragtx.comaudioWCAG2.1-3/13/2025
63031Bluebird. finance.yahoo.comsysiphus-3/13/2025
63030ir.bioatla.com stock collapsed because partnership did not materializeforgetme-3/10/2025
63029abby400 different target and toxin with different linker ascopubs.org meetings.aforgetme-3/8/2025
63028ctmx currently at dose 7th active dose started at level 3 according to ceo fromforgetme13/7/2025
63027For holders of AUPH see news below: finance.yahoo.complhky346513/7/2025
63026Good to see this board still going strong. Top two biotech positions right nowaudioWCAG2.113/7/2025
63025AADI gurufocus.comsysiphus23/6/2025
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News